Pranav R. Santapuram

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma”.

Adverse Events, Treatment Burden, and Outcomes of Intravenous versus Intra-arterial Chemotherapy for Retinoblastoma

Ophthalmology Retina(2020)10.1016/j.oret.2020.09.006

N/A

0DataRank · unranked

10 citations

Emma Schremp, Debra L. Friedman, Tatsuki Koyama, Michael T. Froehler, Anthony B. Daniels +1 more

Efficacy, Toxicity, and Pharmacokinetics of Intra-Arterial Chemotherapy Versus Intravenous Chemotherapy for Retinoblastoma in Animal Models and Patients

Translational Vision Science & Technology(2021)10.1167/tvst.10.11.10

N/A

0DataRank · unranked

17 citations

Michael T. Froehler, Jessica V. Kaczmarek, Carley M. Bogan, Pranav R. Santapuram, Janene Pierce +9 more

Characterizing outcomes in severe cytopenias by 3 months in BCMA and CD19 CAR-T cell therapies: A single institution experience.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e19504

N/A

0DataRank · unranked

1 citations

Manali Rupji, Pranav R. Santapuram, Michael Graiser, Jason T. Romancik, Jonathon B. Cohen +1 more